Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methysergide maleate
Drug ID BADD_D01440
Description An ergot derivative that is a congener of lysergic acid diethylamide. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome.
Indications and Usage For the treatment of vascular headache
Marketing Status approved
ATC Code N02CA04
DrugBank ID DB00247
KEGG ID D00681
MeSH ID D008784
PubChem ID 5281073
TTD Drug ID D0O6GC
NDC Product Code Not Available
UNII 2U7H1466GH
Synonyms Methysergide | Dimethylergometrin | Methylmethylergonovine | UML-491 | UML 491 | UML491 | Sansert | Deseril | Désernil-Sandoz | Désernil Sandoz | Desril | Methysergide Dimaleate | Dimaleate, Methysergide | Methysergide Maleate | Maleate, Methysergide
Chemical Information
Molecular Formula C25H31N3O6
CAS Registry Number 129-49-7
SMILES CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C.C(=CC(=O)O)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pyrexia08.05.02.003--
Rash23.03.13.001--Not Available
Retroperitoneal fibrosis20.06.01.006; 10.02.01.026; 07.07.03.003--Not Available
Seizure17.12.03.001--
Somnolence19.02.05.003; 17.02.04.006--
Telangiectasia24.03.03.003; 23.06.03.001--
Thrombocytopenia01.08.01.002--Not Available
Vomiting07.01.07.003--
Weight increased13.15.01.006--
Muscle swelling15.05.03.015--Not Available
The 2th Page    First    Pre   2    Total 2 Pages